Beone Medicines Ltd. Class A · SSE:688235
Oyler John sold 145,861 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jul 14, 2026 · Filed Jul 14, 2026
On Jul 14, 2026, Oyler John (Director, Chief Executive Officer) sold 145,861 Beone Medicines Ltd. Class A shares at an average US$305.95 for US$44.6M under a trading plan, leaving 0 shares. Filed Jul 14, 2026 (Form 4).
- Sold
- 145,861 shares
- Price
- US$305.95 average (US$303.07 to US$307.57)
- Value
- US$44.6M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | American Depositary Shares | Sale | 4,139 | US$303.07 | 8,122 | Direct |
| Jul 14, 2026 | American Depositary Shares | Sale | 8,122 | US$303.93 | 0 | Direct |
| Jul 14, 2026 | American Depositary Shares | Option exercise | 97,282 | US$36.90 | 97,282 | Direct |
| Jul 14, 2026 | American Depositary Shares | Option exercise | 36,318 | US$100.04 | 133,600 | Direct |
| Jul 14, 2026 | American Depositary Shares | Sale | 39,090 | US$305.02 | 94,510 | Direct |
| Jul 14, 2026 | American Depositary Shares | Sale | 45,895 | US$306.21 | 48,615 | Direct |
| Jul 14, 2026 | American Depositary Shares | Sale | 40,781 | US$306.93 | 7,834 | Direct |
| Jul 14, 2026 | American Depositary Shares | Sale | 7,834 | US$307.57 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Oyler John
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Oyler John · Aug 12, 2026
- Form 4 · Oyler John · Jul 22, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026